Dissociation of CDK2 from Cyclin A in Response to the Topoisomerase II Inhibitor Etoposide in v-src-Transformed but Not Normal NIH 3T3 Cells
- 1 June 1999
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 249 (2) , 327-336
- https://doi.org/10.1006/excr.1999.4484
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- The extracellular matrix and mitogenic growth factors control G1 phase cyclins and cyclin-dependent kinase inhibitorsTrends in Cell Biology, 1997
- Ras Links Growth Factor Signaling to the Cell Cycle Machinery via Regulation of Cyclin D1 and the Cdk Inhibitor p27KIP1Molecular and Cellular Biology, 1997
- Ras signalling linked to the cell-cycle machinery by the retinoblastoma proteinNature, 1997
- Cancer Cell CyclesScience, 1996
- Genetic Alterations of Cyclins, Cyclin-Dependent Kinases, and Cdk Inhibitors in Human CancerAdvances in Cancer Research, 1996
- Ras Transformation Results in an Elevated Level of Cyclin D1 and Acceleration of G1 Progression in NIH 3T3 cellsMolecular and Cellular Biology, 1995
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- Cell cycle regulation in response to DNA damage in mammalian cells: A historical perspectiveCancer and Metastasis Reviews, 1995
- Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycleCell, 1994
- Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 proteinNature, 1984